Australia’s Telix agrees to buy Germany’s ITM Isotope for $1.65 bln
AI Summary
Australia’s Telix Pharmaceuticals announced an agreement to acquire the German company ITM Isotope for $1.65 billion, marking a significant deal in the medical sector.
Australia’s Telix Pharmaceuticals announced an agreement to acquire the German company ITM Isotope for $1.65 billion, marking a significant deal in the medical sector.
The Hill —
CNBC —
Bloomberg —
Vanguard Nigeria —
FreightWaves —
TASS —